Abstract
Liver disease is a potential complication from using dietary supplements. This study investigated an outbreak of non-viral liver disease associated with the use of OxyELITE Pro(TM), a dietary supplement used for weight loss and/or muscle building. Illness details were ascertained from MedWatch reports submitted to the U.S. Food and Drug Administration (FDA) describing consumers who ingested OxyELITE Pro alone or in combination with other dietary supplements. FDA's Forensic Chemistry Center analyzed samples of OxyELITE Pro. From February 2012 to February 2014, FDA received 114 reports of adverse events of all kinds involving consumers who ingested OxyELITE Pro. The onset of illness for the first report was December 2010 and for the last report was January 2014. Thirty-three states, two foreign nations, and Puerto Rico submitted reports. Fifty-five of the reports (48%) described liver disease in the absence of viral infection, gallbladder disease, autoimmune disease, or other known causes of liver damage. A total of 33 (60%) of these patients were hospitalized, and three underwent liver transplantation. In early 2013, OxyELITE Pro products entered the market with a formulation distinct from products sold previously. The new formu...Continue Reading
References
Jul 1, 1985·Journal of Ethnopharmacology·S N ArseculeratneR G Panabokke
Jan 10, 2009·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Robert J FontanaUNKNOWN DILIN Study Group
Jan 28, 2010·The American Journal of Gastroenterology·Tse-Ling FongLeonard B Seeff
Apr 7, 2012·Current Problems in Cancer·Henry S ParkJames B Yu
May 12, 2012·Annals of Emergency Medicine·Paul GeeSuzanne Jackson
Feb 13, 2013·Military Medicine·Michael J EliasonPatricia A Deuster
Jul 4, 2013·Archives of Toxicology·Diana Dias da SilvaElisabete Silva
Dec 18, 2013·The Spine Journal : Official Journal of the North American Spine Society·Emily Jane Woo
Apr 4, 2014·The New England Journal of Medicine·Pieter A Cohen
Citations
Apr 14, 2016·International Journal of Molecular Sciences·Miren García-CortésRaul J Andrade
May 5, 2016·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Philip SargesJames H Lewis
Dec 14, 2016·AACN Advanced Critical Care·Leslie A HamiltonRachel E Collins
Feb 18, 2017·Digestive Diseases and Sciences·Rolf Teschke, Axel Eickhoff
Jun 20, 2018·Clinical Pharmacology and Therapeutics·Marina M RoytmanVictor Navarro
Apr 5, 2016·International Journal of Molecular Sciences·Rolf Teschke, Axel Eickhoff
Nov 25, 2017·The Annals of Pharmacotherapy·Babgaleh B TimboRobert Mozersky
Oct 11, 2017·Annual Review of Pharmacology and Toxicology·Martin J J RonisJames Watt
Jul 2, 2016·Drug Testing and Analysis·Kevin Chatham-StephensLauren Lewis
Feb 10, 2016·Drug Testing and Analysis·Nandakumara SarmaJaap Venema
Sep 4, 2018·Journal of Nutritional Science and Vitaminology·Chiharu NishijimaKeizo Umegaki
Sep 12, 2019·Clinical Liver Disease·Robert J Fontana
Aug 9, 2020·Military Medicine·Melissa RittenhousePatricia Deuster
May 31, 2017·Journal of the American College of Nutrition·Sidney J Stohs, Harry G Preuss
Dec 30, 2015·International Journal of Molecular Sciences·Gaby Danan, Rolf Teschke
Mar 8, 2016·International Journal of Molecular Sciences·Mark I AviganLeonard B Seeff
Dec 1, 2021·Critical Reviews in Food Science and Nutrition·Zhenyu WangZhiyong He